$7.03
0.42%
Nasdaq, Jan 02, 10:00 pm CET
ISIN
IL0010941198
Symbol
KMDA

Kamada Ltd Stock price

$7.03
+0.11 1.59% 1M
-0.71 9.17% 6M
-0.03 0.42% YTD
+0.88 14.24% 1Y
+3.13 80.34% 3Y
+0.73 11.60% 5Y
+2.93 71.36% 10Y
-0.27 3.70% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-0.03 0.42%
ISIN
IL0010941198
Symbol
KMDA
Industry

Key metrics

Basic
Market capitalization
$405.5m
Enterprise Value
$344.5m
Net debt
positive
Cash
$72.0m
Shares outstanding
58.0m
Valuation (TTM | estimate)
P/E
20.1 | 18.8
P/S
2.3 | 2.2
EV/Sales
2.0 | 1.9
EV/FCF
18.4
P/B
1.5
Financial Health
Equity Ratio
69.6%
Return on Equity
5.4%
ROCE
8.4%
ROIC
10.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$174.8m | $184.8m
EBITDA
$43.1m | $44.6m
EBIT
$27.8m | $29.5m
Net Income
$20.5m | $21.7m
Free Cash Flow
$18.8m
Growth (TTM | estimate)
Revenue
10.4% | 14.8%
EBITDA
40.4% | 104.1%
EBIT
56.5% | 47.7%
Net Income
30.2% | 55.3%
Free Cash Flow
-40.7%
Margin (TTM | estimate)
Gross
43.8%
EBITDA
24.6% | 24.2%
EBIT
15.9%
Net
11.7% | 11.8%
Free Cash Flow
10.7%
More
EPS
$0.4
FCF per Share
$0.3
Short interest
0.2%
Employees
420
Rev per Employee
$380.0k
Show more

Is Kamada Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Kamada Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Kamada Ltd forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Kamada Ltd forecast:

Buy
89%
Hold
11%

Financial data from Kamada Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
175 175
10% 10%
100%
- Direct Costs 98 98
7% 7%
56%
76 76
14% 14%
44%
- Selling and Administrative Expenses 35 35
6% 6%
20%
- Research and Development Expense 13 13
19% 19%
7%
43 43
40% 40%
25%
- Depreciation and Amortization 15 15
18% 18%
9%
EBIT (Operating Income) EBIT 28 28
56% 56%
16%
Net Profit 20 20
30% 30%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Kamada Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kamada Ltd Stock News

Neutral
GlobeNewsWire
17 days ago
REHOVOT, Israel, and HOBOKEN, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that the Company has been awarded an extension of an existing tender from the Canadian Blood Services...
Neutral
Seeking Alpha
27 days ago
Kamada Ltd. (KMDA) Discusses Discontinuation of Phase 3 Inhaled AAT Clinical Trial and Financial Outlook Transcript
Neutral
Seeking Alpha
about 2 months ago
Kamada Ltd. ( KMDA ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Conference Call Participants Brian Ritchie - Lifesci Advisors, LLC Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division James Sidoti - Sidoti & Company, LLC Presentation Operator Good morning.
More Kamada Ltd News

Company Profile

Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Mr. London
Employees 420
Founded 1990
Website www.kamada.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today